Physician Assistant, Medical · Garland, TX
NPI
1477827087
Since 2012
Specialty
Physician Assistant, Medical
Code 363AM0700X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
5025 Glen Vista Dr
Garland, TX, 75044
Phone (972) 693-7467
Medicare paid, 2024
$78K
1,300 services
Medicare patients, 2024
156
Average age 70
Drug cost, 2024
$1.2M
5,459 prescriptions
Company payments, 2025
$900
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dipesh R Rana was code 99491 (chronic, principal, and transitional care management), 225 times for 103 patients. In total Dipesh R Rana billed 1,300 services in 30 codes, and Medicare paid $78K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99491 Chronic, Principal, and Transitional Care Management | Office | 225 | 103 | $46.66 | $10K |
| 99350 Home E&M - New and Established | Office | 169 | 96 | $94.85 | $16K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 129 | 70 | $34.30 | $4,425 |
| G0181 Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 115 | 66 | $55.63 | $6,398 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 111 | 110 | $8.34 | $926 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 105 | 105 | $98.51 | $10K |
| 99497 Care Management/Coordination | Office | 96 | 95 | $40.93 | $3,929 |
| 99214 Office E&M - Established | Office | 82 | 69 | $73.89 | $6,059 |
| 99483 Office/Outpatient Services | Office | 80 | 75 | $156.80 | $13K |
| 99349 Home E&M - New and Established | Office | 39 | 35 | $64.65 | $2,521 |
| 96127 Behavioral Health Services | Office | 39 | 18 | $3.12 | $122 |
| G0506 Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | Office | 26 | 25 | $36.43 | $947 |
| 99348 Home E&M - New and Established | Office | 12 | 12 | $46.13 | $554 |
By year: 2022 $108K for 1,605 services; 2023 $107K for 1,505 services; 2024 $78K for 1,300 services.
Medicare prescription drug claims, 2024
In 2024, the drug Dipesh R Rana prescribed most often to Medicare patients was Acetaminophen-Codeine (Acetaminophen With Codeine), with 235 prescriptions and refills. In total Dipesh R Rana wrote 5,459 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acetaminophen-Codeine Acetaminophen With Codeine | 235 | 237 | 38 | $4,203 |
| Diclofenac Sodium Generic | 215 | 216 | 69 | $106K |
| Famotidine Generic | 189 | 212 | 41 | $44K |
| Alprazolam Generic | 178 | 184 | 22 | $729 |
| Gabapentin Generic | 171 | 480 | 65 | $3,368 |
| Atorvastatin Calcium Generic | 142 | 413 | 61 | $1,173 |
| Amlodipine Besylate Generic | 138 | 403 | 55 | $597 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 121 | 213 | 42 | $8,347 |
| Lisinopril Generic | 107 | 315 | 35 | $661 |
| Metformin Er Gastric Metformin Hcl | 95 | 191 | 35 | $89K |
| Promethazine Hcl Generic | 90 | 95 | 28 | $978 |
| Levocetirizine Dihydrochloride Generic | 87 | 250 | 32 | $1,332 |
| Montelukast Sodium Generic | 78 | 222 | 29 | $808 |
| Amoxicillin Generic | 73 | 73 | 22 | $267 |
| Lidocaine Generic | 73 | 90 | 29 | $7,669 |
Brand drugs: 791 claims; generic drugs: 4,568 claims; opioid claims: 299.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dipesh R Rana $900 ($900 in general payments such as food, travel and fees) from 13 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $325.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 14 | $325 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 8 | $168 |
| Dexcom, Inc. DXCM | 3 | $60.6 |
| Exact Sciences Corporation EXAS | 2 | $57.1 |
| Abbvie Inc. ABBV | 3 | $52.48 |
| Axsome Therapeutics, Inc. AXSM | 2 | $49.02 |
| Amgen Inc. AMGN | 2 | $38.76 |
| Lilly USA, LLC LLY | 2 | $31.4 |
| GlaxoSmithKline, LLC. GSK | 2 | $30.73 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 1 | $23.25 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.